PROTEOMICS · 2004 · 43 citations · 30 references
Cell AdhesionPathologyExtracellular MicrovesiclesCancer BiologyTumor BiologySignaling PathwayCancer Cell BiologyMatrix BiologyCell SignalingMolecular SignalingSmad4 ExpressionCell BiologyTumor MicroenvironmentMass SpectrometryCell-matrix InteractionTumor Suppressor Smad4Differential SecretomicsTumor SuppressorSystems BiologyMedicineExtracellular Matrix
We have demonstrated previously that restoration of Smad4 expression in Smad4-deficient SW480 human colon carcinoma cells was adequate to suppress tumorigenicity and invasive potential, whereas cell growth in vitro was not affected. Here we show that Smad4-positive and Smad4-negative SW480 cells deposit extracellular matrices in tissue culture which are functionally different with respect to their adhesiveness. We present a "differential secretomics analysis" as the most direct approach to identify the underlying alterations. The protein composition of conditioned media produced by Smad4-positive and Smad4-negative SW480 cells was compared by two-dimensional (2-D) gel electrophoresis. A major group of protein spots was detected in media derived from Smad4-negative cells, only, which were identified as "secreted protein, acidic and rich in cysteins" (SPARC) by mass spectrometry. SPARC expression in SW480 cells was suppressed by Smad4 at the level of transcription. SPARC is a glycoprotein of the extracellular matrix, characterized as an anti-adhesive and invasion-promoting protein. Differential secretomics appeared as a powerful method to identify a novel Smad4 target gene, which may be one of the players involved in reduced adhesiveness of extracellular matrices and thus consistent with Smad4's emerging role as an invasion suppressor.
30
<i>DPC4</i> , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Stephan A. Hahn, Mieke Schutte, A.T.M. Shamsul Hoque et al. · Science · 1996 · 2.3K citations
Joan Massagué, Ye‐Guang Chen · Genes & Development · 2000 · 1.6K citations · Full text
Signal Transduction, Signaling Pathway, Receptor Tyrosine Kinase +3